Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness.
Folcher A, Gordienko D, Iamshanova O, Bokhobza A, Shapovalov G, Kannancheri-Puthooru D, Mariot P, Allart L, Desruelles E, Spriet C, Diez R, Oullier T, Marionneau-Lambot S, Brisson L, Geraci S, Impheng H, Lehen'kyi V, Haustrate A, Mihalache A, Gosset P, Chadet S, Retif S, Laube M, Sobilo J, Lerondel S, Villari G, Serini G, Pla AF, Roger S, Fromont-Hankard G, Djamgoz M, Clezardin P, Monteil A, Prevarskaya N. Folcher A, et al. Among authors: clezardin p. EMBO J. 2023 Jul 3;42(13):e112198. doi: 10.15252/embj.2022112198. Epub 2023 Jun 6. EMBO J. 2023. PMID: 37278161 Free PMC article.
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
Puppo M, Croset M, Ceresa D, Valluru MK, Canuas Landero VG, Hernandez Guadarrama M, Iuliani M, Pantano F, Dawn Ottewell P, Clézardin P. Puppo M, et al. Among authors: clezardin p. Breast Cancer Res. 2024 Dec 18;26(1):186. doi: 10.1186/s13058-024-01934-2. Breast Cancer Res. 2024. PMID: 39696397 Free PMC article.
Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases.
Mabrut E, Mainbourg S, Peron J, Maillet D, Dalle S, Fontaine Delaruelle C, Grolleau E, Clezardin P, Bonnelye E, Confavreux CB, Massy E. Mabrut E, et al. Among authors: clezardin p. J Bone Oncol. 2024 Sep 21;48:100634. doi: 10.1016/j.jbo.2024.100634. eCollection 2024 Oct. J Bone Oncol. 2024. PMID: 39381634 Free PMC article.
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.
Puppo M, Valluru MK, Croset M, Ceresa D, Iuliani M, Khan A, Wicinski J, Charafe-Jauffret E, Ginestier C, Pantano F, Ottewell PD, Clézardin P. Puppo M, et al. Among authors: clezardin p. Br J Cancer. 2023 Sep;129(5):754-771. doi: 10.1038/s41416-023-02340-9. Epub 2023 Jul 13. Br J Cancer. 2023. PMID: 37443350 Free PMC article.
Non-coding RNA in rhabdomyosarcoma progression and metastasis.
Ramadan F, Saab R, Hussein N, Clézardin P, Cohen PA, Ghayad SE. Ramadan F, et al. Among authors: clezardin p. Front Oncol. 2022 Aug 11;12:971174. doi: 10.3389/fonc.2022.971174. eCollection 2022. Front Oncol. 2022. PMID: 36033507 Free PMC article. Review.
175 results